COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice

被引:150
作者
Sigthorsson, G
Simpson, RJ
Walley, M
Anthony, A
Foster, R
Hotz-Behoftsitz, C
Palizban, A
Pombo, J
Watts, J
Morham, SG
Bjarnason, I
机构
[1] Guys Kings St Thomas Sch Med, Dept Med, London SE5 9PJ, England
[2] UCL Royal Free & Univ London Med Sch, Dept Histol, London, England
[3] Myriad Genet Inc, Salt Lake City, UT USA
关键词
D O I
10.1053/gast.2002.33647
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: The pathogenesis of nonsteroidal anti-inflammatory drug-induced enteropathy is controversial, but it is thought that cyclooxygenase-1 (COX-1) inhibition is of pivotal importance. We compared small intestinal function and morphology in untreated wildtype, COX-1- and COX-2- deficient mice and the effect of indomethacin, selective COX-1 (SC-560), and COX-2 (celecoxib) inhibition. Methods: Intestinal permeability ((51)CrEDTA), inflammation (fecal granulocyte marker protein), prostaglandin E-2 (PGE(2)) levels, and macroscopic and microscopic appearances were assessed at baseline and after the drugs. Results: COX-1(-/-) animals were normal except for a 97% decrease in intestinal PGE2 levels. COX-1(+/+) and COX-1(-/-) animals reacted in a similar way to indomethacin. However, celecoxib, having caused no damage in COX-1(+/+) animals, caused small bowel ulcers in COX-1(-/-) animals. Selective inhibition of COX-I decreased intestinal PGE2 levels in COX-2(+/+) and COX-2(-/-) animals by 95%-97%, but caused only small bowel ulcers in the latter group. Dual inhibition of COX-1 and COX-2 in wild-type animals resulted in similar small bowel damage. Between 40% and 50% of untreated COX-2(-/-) animals had increased intestinal permeability and inflammation. Some had ileal ulcers that were distinctively different from indomethacin-induced ulcers. Furthermore, long-term celecoxib administration in wildtype animals was associated with similar damage as in the COX-2(-/-) mice. Conclusions: COX-1 deficiency or inhibition and short-term COX-2 inhibition are compatible with normal small intestinal integrity. Dual inhibition of the COX enzymes leads to damage similar to that seen with indomethacin. Long-term COX-2 deficiency or inhibition is associated with significant intestinal pathology despite normal intestinal PGE2 levels, suggesting a role for COX-2 in the maintenance of small intestinal integrity in the mouse.
引用
收藏
页码:1913 / 1923
页数:11
相关论文
共 63 条
[1]   GASTROINTESTINAL DAMAGE ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
ALLISON, MC ;
HOWATSON, AG ;
TORRANCE, CJ ;
LEE, FD ;
RUSSELL, RI .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (11) :749-754
[2]  
Anand BS, 1999, AM J GASTROENTEROL, V94, P1818
[3]  
ANTHONY A, 1993, ALIMENT PHARM THER, V7, P29
[4]   Vascular anatomy defines sites of indomethacin induced jejunal ulceration along the mesenteric margin [J].
Anthony, A ;
Pounder, RE ;
Dhillon, AP ;
Wakefield, AJ .
GUT, 1997, 41 (06) :763-770
[5]   NONSTEROIDAL ANTIINFLAMMATORY DRUGS AND LIFE THREATENING COMPLICATIONS OF PEPTIC-ULCERATION [J].
ARMSTRONG, CP ;
BLOWER, AL .
GUT, 1987, 28 (05) :527-532
[6]  
BJARNASON I, 1987, LANCET, V2, P711
[7]   SIDE-EFFECTS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS ON THE SMALL AND LARGE-INTESTINE IN HUMANS [J].
BJARNASON, I ;
HAYLLAR, J ;
MACPHERSON, AJ ;
RUSSELL, AS .
GASTROENTEROLOGY, 1993, 104 (06) :1832-1847
[8]   INTESTINAL PERMEABILITY TO CR-51-EDTA IN RATS WITH EXPERIMENTALLY INDUCED ENTEROPATHY [J].
BJARNASON, I ;
SMETHURST, P ;
LEVI, AJ ;
PETERS, TJ .
GUT, 1985, 26 (06) :579-585
[9]   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[10]  
BRUNE K, 1987, SCAND J RHEUMATOL, P135